Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA confirms scope of Cheltenham racecourse review
The review is expected to conclude in summer 2018.
Racing body to conduct review after racehorse deaths 

A review is set to examine all recent equine fatalities and long-term injuries at Cheltenham racecourse and the Cheltenham Festival, the British Horseracing Authority (BHA) has confirmed.

The move comes shortly after the deaths of six horses at this year’s four-day festival in March.

BHA is aiming to adopt an evidence-based approach to improving equine welfare, to reduce risks for horses, demonstrate openness and transparency and use relvant expertise to inform the review process.

The review will focus on the following areas: courses, obstacles, participant factors, starts, safety factors and race tempo, programming and race conditions, and veterinary aspects.

It will be led by Brant Dunshea, BHA’s director of integrity and regulatory operations, and co-ordinated by Emma Marley, head of racecourse operations. Relevant internal and experts will also assist the process, including organisations such as the RSPCA and World Horse Welfare.

The review is expected to conclude in summer 2018, to allow recommendations to be implemented ahead of the 2018/19 jump season.

BHA also recently announced it would look at whether existing penalties for misuse of the whip offer an adequate deterrent for jockeys. This topic will be discussed by the board before the scope and timings are finalised.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'